Randomized Phase III Clinical Trial Of Adjuvant Radiation Versus Chemoradiation In Intermediate Risk, Stage I/IIa Cervical Cancer Treated With Initial Radical Hysterectomy And Pelvic Lymphadenectomy
Posted Date: May 22, 2020
- Investigator: Thomas Herzog
- Specialties: Cancer, Cervical Cancer, Oncology
- Type of Study: Drug
The goal of this study is to determine if post-operative adjuvant chemo-radiation therapy (CRT) can significantly improve recurrence-free survival (RFS) when compared to radiation therapy (RT) alone in Stage I-IIA cervical cancer patients with intermediate risk factors after treatment with radical hysterectomy
Criteria:
To Be Eligible: Must Have Primary Cervical Cancer I-Iia, Adequate Organ Function, Gog Performance Status 0-2, No Severe Infection, No Previous Rt Or Chemo For Study Cancer, No Prior Malignancy Within 5 Years
Keywords:
Cervical Cancer, Chemoradiation
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com